PT  - JOURNAL ARTICLE
AU  - D E Bax
AU  - R S Amos
TI  - Sulphasalazine: a safe, effective agent for prolonged control of rheumatoid arthritis. A comparison with sodium aurothiomalate.
AID  - 10.1136/ard.44.3.194
DP  - 1985 Mar 01
TA  - Annals of the Rheumatic Diseases
PG  - 194--198
VI  - 44
IP  - 3
4099  - http://ard.bmj.com/content/44/3/194.short
4100  - http://ard.bmj.com/content/44/3/194.full
SO  - Ann Rheum Dis1985 Mar 01; 44
AB  - The place of sulphasalazine in the management of rheumatoid arthritis over prolonged periods of time has been compared and contrasted with that of sodium aurothiomalate. One hundred and forty-three patients (59 on sulphasalazine, 84 on sodium aurothiomalate) have been treated for periods of up to 42 months. Sulphasalazine is highly effective for some patients, though probably less frequently than sodium aurothiomalate. However, its safety profile is far superior, and very long-term treatment with sulphasalazine is a safe option for treatment of rheumatoid arthritis.